Chinese SFDA Probes Roche’s Alleged Adverse Event Concealment
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA said that it has arranged to meet with Roche Holding AG’s Chinese quality controller over the company’s alleged concealment of adverse events, reported by overseas media.